As of 2024-12-13, the Intrinsic Value of Rain Therapeutics Inc (RAIN) is
-8.00 USD. This RAIN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.21 USD, the upside of Rain Therapeutics Inc is
-760.80%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-8.00 USD
Intrinsic Value
RAIN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-8.00 - -8.00 |
-8.00 |
-760.80% |
| P/E |
(39.82) - (47.49) |
(43.58) |
-3701.4% |
| DDM - Stable |
(18.37) - (125.27) |
(71.82) |
-6035.7% |
| DDM - Multi |
(18.72) - (100.33) |
(31.66) |
-2716.8% |
RAIN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
54.67 |
| Beta |
1.10 |
| Outstanding shares (mil) |
45.18 |
| Enterprise Value (mil) |
17.37 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.62% |
| Cost of Debt |
5.00% |
| WACC |
5.65% |